Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director · See Remarks | July 15, 2026 | July 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date July 15, 2026 · Filed July 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 741,657 |
Ending reported balance
After 2026-07-15 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-07-15 · Exercise / conversion · Acquired 115,148 · Balance 699,973 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2026-07-15 · Tax withholding · Disposed 50,021 · Balance 649,952 Row 3 · 2026-07-15 · Exercise / conversion · Acquired 51,177 · Balance 701,129 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 4 · 2026-07-15 · Tax withholding · Disposed 22,232 · Balance 678,897 Row 5 · 2026-07-15 · Exercise / conversion · Acquired 110,963 · Balance 789,860 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 6 · 2026-07-15 · Tax withholding · Disposed 48,203 · Balance 741,657 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,151,484 |
Reported balance
After 2026-07-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-07-15 · Exercise / conversion · Disposed 115,148 · Balance 1,151,484 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 102,354 |
Reported balance
After 2026-07-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-07-15 · Exercise / conversion · Disposed 51,177 · Balance 102,354 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,109,631 |
Reported balance
After 2026-07-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-07-15 · Exercise / conversion · Disposed 110,963 · Balance 1,109,631 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters.
F3: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters.
F4: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 110,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · derivative · entry 9 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,109,631 Underlying: Class A Common Stock · 110,963 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 51,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · derivative · entry 8 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,354 Underlying: Class A Common Stock · 51,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 115,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · derivative · entry 7 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,151,484 Underlying: Class A Common Stock · 115,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 48,203 | $3.01 | $145,091.03 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 6 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 741,657 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 110,963 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 5 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 789,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 22,232 | $3.01 | $66,918.32 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 4 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 678,897 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 51,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 3 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 701,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 50,021 | $3.01 | $150,563.21 |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 649,952 Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 20:25 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 115,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000137 · wk-form4_1784233543.xml · nonDerivative · entry 1 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 699,973 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 110,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · derivative · entry 9 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,220,594 Underlying: Class A Common Stock · 110,963 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F4 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F4 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 51,177 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · derivative · entry 8 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,531 Underlying: Class A Common Stock · 51,177 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 115,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · derivative · entry 7 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,266,632 Underlying: Class A Common Stock · 115,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 48,203 | $2.23 | $107,492.69 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 6 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 584,825 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 110,963 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 5 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 633,028 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 22,232 | $2.23 | $49,577.36 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 4 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 522,065 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 51,177 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 3 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 544,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 50,021 | $2.23 | $111,546.83 |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 493,120 Read SEC document |
| April 15, 2026 Filed Apr 15, 2026 21:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 115,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000074 · wk-form4_1776290059.xml · nonDerivative · entry 1 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 543,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 01:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 1,331,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000044 · wk-form4_1772759299.xml · derivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,331,557 Underlying: Class A Common Stock · 1,331,557 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. F2 · derivative.expiration_date: The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date. Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 204,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · derivative · entry 6 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,708 Underlying: Class A Common Stock · 204,708 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters. Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 460,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · derivative · entry 5 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,381,780 Underlying: Class A Common Stock · 460,594 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 88,926 | $2.75 | $244,546.50 |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · nonDerivative · entry 4 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 427,993 Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 204,708 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · nonDerivative · entry 3 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 148,383 | $2.75 | $408,053.25 |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · nonDerivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,211 Read SEC document |
| January 15, 2026 Filed Jan 15, 2026 22:19 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 460,594 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-26-000006 · wk-form4_1768515552.xml · nonDerivative · entry 1 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 460,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 2,828,232 | $0.00 Strike: $4.85 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 3 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,828,232 Underlying: Class A Common Stock · 2,828,232 shares Expires 2035-03-03 F4 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to early exercise and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 409,416 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 2 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,416 Underlying: Class A Common Stock · 409,416 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3 · derivative.exercise_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters. F3 · derivative.expiration_date: The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% underlying shares to vest in approximately equal quarterly installments thereafter for 4 quarters. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:46 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 1,842,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-25-000044 · wk-form4_1741214773.xml · derivative · entry 1 Barnes Wendy Lynn · CIK 0002049585 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,842,374 Underlying: Class A Common Stock · 1,842,374 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 25% of the underlying shares on January 15, 2026 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.